What opportunities exist in Tunisia's pharmaceutical sector?

Quelles opportunites dans le secteur pharmaceutique tunisien?

Confidence: high Reviewed: 2026-04-08 EN FR

Short Answer

Tunisia covers 55% of domestic pharma needs (400M USD market). 50+ manufacturing plants, 70 labs, 15,000 direct jobs. Key players: Adwya, Saiph, Medis, Teriak. Exports to 30+ African countries. Opportunities: generics for Africa, clinical trials hub, biotech, medical cannabis (law in preparation). API manufacturing growing. EU GMP-certified facilities. Government target: 80% local production by 2030.

Version francaise

La Tunisie couvre 55% de ses besoins pharma (marche 400M USD). 50+ usines, 70 labos. Acteurs: Adwya, Saiph, Medis. Exports vers 30+ pays africains. Opportunites: generiques Afrique, essais cliniques, biotech.

Limitations & Caveats

Data reflects latest available official sources. Some figures may have a 6-12 month lag. Estimates are clearly labeled.

Review & Confidence

Last reviewed2026-04-08
Expires2026-09-30
Refreshquarterly
Confidence high
LicenseCC-BY-4.0

Author & Reviewer

Authorwelovetunisia.com Editorial Team
ReviewerMohamed Nizar Yaiche
MethodologyReview process

Machine Formats

Tags

investment pharma healthcare manufacturing africa

Other Questions